Howe & Rusling’s IDEAYA Biosciences IDYA Stock Holding History

Howe & Rusling’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-40	Closed	–	–	1110
2022 Q1	$0	Hold	40	–	–	﹤0.01%	1036
2021 Q4	$1K	Hold	40	–	–	﹤0.01%	933
2021 Q3	$1K	Buy	+40	New	+$934	﹤0.01%	923

Other funds holding IDYA

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

CPX

Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Howe & Rusling's IDYA Position: Q2 2022 in Review

Howe & Rusling sold out of IDEAYA Biosciences (IDYA) in Q2 2022, closing a stake of 40 shares.

Howe & Rusling first reported a position in IDYA in Q3 2021 and held it in 3 quarters. The position peaked at $1K in Q4 2021. 96 funds tracked by Wall St. Rank hold IDYA as of Q2 2022.

Howe & Rusling reported no remaining IDEAYA Biosciences position as of Q2 2022 after selling out during the quarter.
Howe & Rusling sold 40 IDEAYA Biosciences shares in Q2 2022.
Howe & Rusling first reported a position in IDEAYA Biosciences in Q3 2021 and held it in 3 quarters.
Howe & Rusling's IDEAYA Biosciences position peaked at $1K in Q4 2021.
96 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2022.

Based on Howe & Rusling's 13F filing for Q2 2022, filed 15 Aug 2022.